Malta Awards €12.26 Million Dexcom Glucose Monitoring Contract for National Healthcare Supply

Introduction

Malta has awarded a major healthcare procurement contract aimed at expanding diabetes care services nationwide. The Central Procurement and Supplies Unit (CPSU), under the Ministry for Health and Active Ageing, has granted a €12.26 million supply contract to A.T.G Co. Ltd for the provision of Dexcom continuous glucose monitoring systems. The contract was finalized on March 19, 2026.

Contract Details and Scope

The awarded tender (Notice Ref: 194077-2026, TOT Ref No: 25074845) carries a total contract value of €12,264,000 and was issued through a negotiated procurement procedure.

The scope covers the supply, servicing, and maintenance of Dexcom G7 Continuous Glucose Monitoring Systems (CGMS), including:

• Dexcom G7 glucose monitoring devices
• Medical consumables and accessories
• Required supporting equipment for patient use
• Ongoing maintenance and technical support

The contract also includes integration with the Dexcom Clarity Application, enabling patients to continuously monitor interstitial glucose levels digitally through connected health platforms. Supply and service coverage will continue through December 2027.

Entities Involved

The contracting authority, Central Procurement and Supplies Unit, manages strategic public healthcare tenders across Malta, ensuring medical supply continuity for national health programs.

The awarded supplier, A.T.G Co. Ltd, based in Qormi, Malta, is a recognized distributor of healthcare products and medical technologies. Its selection reflects its capacity to deliver specialized diabetes monitoring systems at national scale.

Healthcare and Social Significance

This contract award represents a major advancement in Malta’s diabetes management strategy. Continuous glucose monitoring technology significantly improves patient outcomes by enabling real-time glucose tracking and reducing risks associated with unmanaged blood sugar fluctuations.

Expected benefits include:

• Improved diabetes monitoring accuracy for patients
• Reduced emergency complications linked to glucose instability
• Enhanced quality of life for insulin-dependent patients
• Greater digital integration in chronic disease care

Such awarded tenders are essential in modernizing healthcare delivery and supporting long-term public health outcomes.

Technical and Procurement Insights

The negotiated procedure suggests specialized procurement conditions, often used where proprietary medical technology or exclusive supplier arrangements apply. Dexcom systems require technical compatibility, patient training support, and reliable supply chains for consumables.

The inclusion of maintenance and digital app integration reflects Malta’s broader move toward connected healthcare systems and digital patient monitoring.

Conclusion

The €12.26 million Dexcom supply contract marks a significant milestone in Malta’s procurement news and public healthcare investment strategy. As implementation continues through 2027, the project is expected to improve diabetes care standards nationwide and strengthen access to advanced medical technology.

This government contract underscores Malta’s commitment to patient-centered healthcare innovation and chronic disease management excellence.

#Malta tenders, #Dexcom glucose monitors Malta, #healthcare,  #Contract award Malta, #continuous glucose monitoring Europe, #A.T.G Co Ltd Malta, #Malta procurement, #diabetes care Malta, #government healthcare contracts Europe, #procurement news Malta, #awarded tenders, #medical devices